Efficacy of Denifanstat for the Treatment of Metabolic Dysfunction–Associated Steatohepatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Gastroenterology & Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial
Lancet Gastroenterol Hepatol 2024 Oct 10;[EPub Ahead of Print], R Loomba, P Bedossa, K Grimmer, G Kemble, E Bruno Martins, W McCulloch, M O'Farrell, WW Tsai, J Cobiella, E Lawitz, M Rudraraju, SA HarrisonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.